About David Cohen
David Cohen is a director at Evommune.
David Cohen reports to the SEC as a director of 5 public companies, including Timber Pharmaceuticals (TMBR), Kadmon (KDMN) and Dermira (DERM).
David Cohen first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name David Cohen in the role, so the role may have started earlier or lasted longer.
TI
Timber Pharmaceuticals, Inc.
Director
2020 – 2023 · Public company (TMBR)
KI
Kadmon Holdings, Inc.
Director
2019 – 2021 · Public company (KDMN)
DI
Dermira, Inc.
Director
2014 – 2020 · Public company (DERM)
CC
Connetics Corp.
Director
2006 – 2007 · Public company (CNCT)
Key Colleagues at Startups
The people David Cohen works with at each company, as listed on that company's latest Form D.
Evommune, Inc. · Form D, Jan 8, 2025
JD
Janice Drew
Executive officer
RH
Robert Hopfner
Director
DD
Derek DiRocco
Director
GM
Gregory Moss
Chief Business and Legal Officer
EB
Eugene Bauer
Executive officer and director
FW
Felice Verduyn-van Weegen
Director
FB
Francois Beaubien
Director
JP
Jeegar Patel
Executive officer
YY
Yuexin Yu
Director
BM
Benjamin McGraw
Director
LP
Luis Pena
Executive officer and director
KC
Kyle Carver
Executive officer